Overview

Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

Status:
Recruiting

Trial end date:
2023-06-01

Target enrollment:

Participant gender:

Summary

A multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy of tradipitant in the treatment of motion sickness.

Phase:

Phase 3

Details

Lead Sponsor:

Vanda Pharmaceuticals